<DOC>
	<DOCNO>NCT01111955</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability pharmacodynamic effect fast plasma glucose ( FPG ) .</brief_summary>
	<brief_title>Safety Study BMS-823778 Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes mellitus Drug naive stable metformin therapy HbA1c 710 % FPG â‰¤ 240mg/dL History myocardial infarction , coronary angioplasty bypass graft , valvular disease repair , unstable angina pectoris , transient ischemic attack , cerebrovascular accident within six month prior entry study Congestive heart failure Active liver disease Impaired renal function Hepatitis C , B HIV This list inclusive ; additional information provide protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>